Patterns of cancer recurrence in localized resected hepatocellular carcinoma
Aryavarta MS Kumar, Elisha T Fredman, Christopher Coppa, Galal El-Gazzaz, Federico N Aucejo and May Abdel-Wahab
Cleveland, USA
Author Affiliations: Department of Radiation Oncology, 9500 Euclid Ave, T28, Cleveland Clinic (Kumar AMS, Fredman ET and Abdel-Wahab M); Department of Radiology, 9500 Euclid Ave, Hb6, Cleveland Clinic (Coppa C); and Department of Hepato-pancreato-biliary & Transplant Surgery, 9500 Euclid Ave, A100 (El-Gazzaz G and Aucejo FN), Cleveland OH 44195, USA
Corresponding Author: Aryavarta MS Kumar, MD, PhD, Radiation Oncology, 6525 Powers Blvd, Parma OH 44129, USA (Tel: 440-743-4749; Fax: 440-743-4716; Email: aryavarta.kumar@gmail.com)
BACKGROUND: Tumor resection in non-metastatic hepatocellular carcinoma (HCC) patients with adequate liver reserve offers a potential cure, but has a high 5-year recurrence rate. We analyzed the patterns of cancer relapse after partial hepatectomy to guide post-operative management.
METHODS: A total of 144 HCC patients (1996-2011) after partial hepatectomy were reviewed. Statistical correlations were determined using univariate and partition analyses.
RESULTS: A median follow-up of 20 months showed recurrence in 71 (49%) patients, and the median time to recurrence was 11.9 months. Vascular invasion (P<0.01) and number of lesions (P<0.01) predicted for recurrence. Histologic grade was not correlated with recurrence. Twenty-two (31%) patients developed both surgical margin (SM) and concurrent intrahepatic recurrences, and 28 (40%) had non-SM intrahepatic recurrences with no other signs of recurrence. On partition analysis, the risk of marginal recurrence in patients with SM <1 mm and SM ≥1 mm was 35% and 13.5% respectively. Approximately 57% of patients with intrahepatic recurrence had recurrence ≤2.5 cm from SM.
CONCLUSIONS: Intrahepatic recurrence after partial hepatectomy is common and is significantly associated with vascular invasion and tumor stage. About 57% of patients with intrahepatic relapse had a recurrence close (≤2.5 cm) to the SM. Additionally, patients with SM <1 mm have a higher recurrence rate and may benefit from adjuvant local therapy.
2015, Vol. 14 
